PATRICIA KRAUSE: Open Payments
NPI 1801917844 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 55 payments from 18 companies in 2025. Trend: 2023 $1,328 · 2024 $1,401 · 2025 $1,081
Food & beverage: $1,081
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $188 |
| Travere Therapeutics, Inc. | 8 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $89 |
| Alexion Pharmaceuticals, Inc. | 3 | $84 |
| Ardelyx, Inc. | 4 | $79 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Amgen Inc. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
Products named: Fabhalta, Kerendia, ULTOMIRIS, IBSRELA, BENLYSTA, JARDIANCE, TAVNEOS, FARXIGA.
Industry payments across MI — which companies pay providers there.
